WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 23-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 14'5601 Infant (under 12 months) mortality rate: 112
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 132

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 43'417  42'980  42'538  42'095  41'656  37'057  32'730  28'106 
Births 753  754  754  753  751  720  714  692 
Surviving infants 744  744  744  742  741  707  696  668 
Pop. less than 5 years 3'718  3'705  3'680  3'654  3'640  3'472  3'415  3'317 
Pop. less than 15 years 10'939  10'894  10'833  10'764  10'705  10'370  10'020  8'524 
Female 15-49 years 10'804  10'701  10'601  10'503  10'400  9'192  7'820  6'753 

Number of reported cases

(Click for retrospective incidence data for Argentina)
Diphtheria
ChartChart
  31  86 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  1'967  16'102 
Mumps
ChartChart
  156  87  3'772  4'619  5'481 
Pertussis
ChartChart
  975  561  1'112  1'239  3'185  515  2'012  27'223 
Polio*
ChartChart
  32 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  10  11  10  12  49  219 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Argentina)
Vaccine year result method % card seen                                                
BCG          99*  99*  99*  99*  99*  99  99*  62 
DTP1          94  98  94  94  94  88 
DTP3          87  94  94  91  93  83  87  44 
DTP4          74  84 
IPV1         
HepB_BD          84  87  85  88  85 
HepB3          87  94  94  91  93 
Hib3          87  94  94  91  93  83 
JapEnc         
MCV1          81  95  94  94  95  91  93  61 
MCV2          86  96  82  90  91  91 
PCV1          92  99  98  69 
PCV3          82  89  86  41 
Pol3          87  92  90  90  93  88  90  33 
Rota1          83 
RotaC         
Rubella1          81  95  94  94  95 
TT2plus 2011  43  MICS     62  95  78  42 
PAB         
VAD1         
YFV          60  51  91  89  93 
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Argentina)
BCG
ChartChart
  99  99  99  99  99  99  62 
DTP1
ChartChart
  98  94  94  94  96  95  69 
DTP3
ChartChart
  94  94  91  92  83  87  44 
HepB3
ChartChart
  94  94  91  92 
HepB_BD
ChartChart
  85  85  88  85 
Hib3
ChartChart
  94  94  91  92  83 
MCV1
ChartChart
  95  94  94  95  91  93  61 
MCV2
ChartChart
  85  82  90  91  91 
PCV3
ChartChart
  89  86  41 
Pol3
ChartChart
  92  90  90  93  88  90  33 
RotaC
ChartChart
 
YFV
ChartChart
  12 

Number of districts in the country 511  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG Birth; Yes
CHOLERA Yes militaries
DTaPHibHepIPV Yes for premature babies <1500g
DTwP 6 years; Yes
DTwPHiB 15-18 months; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HIB Yes special groups
HPV 11 years (x3) Yes
HepA 12 months; Yes
HepB_Adult Yes
HepB_Pediatric birth; Yes
IPV Yes special groups
Influenza_Adult => 65 years; Yes and adults with chronic diseases, pregnant women, health care workers and other risk groups
Influenza_Pediatric 6-24 months; Yes and children with chronic diseases
MMR 1, 6 years; Yes and Y11 if not yet vaccinated
MenACWY Yes special groups
OPV 2, 4, 6, 18 months; 6 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps > 65 years; Yes and risk groups
Td 16 years; Yes every 10 years
Tdap 11 years; Yes HCW and PW
Typhoid Yes Militaries
Varicella Yes special groups
YF 12 months; No

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2016  2011-2016  2010-2015  2012-2016  2010-2015  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number   24  24  129    24  24 

System performance

Total Nº districts in country number 511  511  511    511  511  547 
Nº districts with DTP3 coverage >=80% number 440  452  430  381  349  427   
% of districts with DTP3 coverage >=80% From 0 to 100% 86  88  84    68  84   
Nº districts with measles (MCV1) coverage >=95% number 286  295  270  254  259  313   
% of districts with MCV1 coverage >=95% From 0 to 100% 56  58  53    51  61   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  60  100  100  100     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.